Using a combination of approaches, researchers characterized influenza A viruses at two live animal swine markets in Minnesota.
Researchers saw high recurrence risk in oropharyngeal carcinoma patients with human papillomavirus type 16 DNA in their spit samples both before and after treatment.
Roche's Cobas EGFR v2 mutation test will be able to identify advanced NSCLC patients with EGFR mutations who are likely to benefit from the next-generation treatment.
Qiagen posted revenues of $319.5 million compared to $330.8 million in the year-ago period, and beat analysts' consensus estimate on the top and bottom lines.
The firm increased its MDx revenues 7 percent from a year ago and beat the consensus Wall Street estimates on the top and bottom lines.
In Science this week: caution urged in use of gene drives, and more.
NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.
PLOS Biology has asked researchers how they envision the future of genetics and genomics.
Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."